Compare Amylx Pharmaceuticals Inc (AMLX) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Tenet Healthcare Corporation — how do they compare? Amylx Pharmaceuticals Inc trades at $23.72 (market cap $2.64B), while Tenet Healthcare Corporation trades at $261.26 (market cap $20.89B). The key difference: Tenet Healthcare Corporation is far larger — about 7.9× Amylx Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| AMLX | THC | |
|---|---|---|
Market Cap | $2.64B | $20.89B |
Sector | Health | Health |
52-Week High | $24.19 | $262.63 |
52-Week Low | $7.82 | $161.37 |
Enterprise Value | $2.39B | $31.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
